APA (7th ed.) Citation

JL, G. M., E, M., A, N., SA, W., & AM, B. (2026). Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer. Cancer cell, 44(2), 254. https://doi.org/10.1016/j.ccell.2026.01.004

Chicago Style (17th ed.) Citation

JL, Gomez Marti, Michaels E, Nasrazadani A, Wander SA, and Brufsky AM. "Enhancing Therapeutic Outcomes with Artificial Intelligence for HR-positive, HER2-negative Metastatic Breast Cancer." Cancer Cell 44, no. 2 (2026): 254. https://doi.org/10.1016/j.ccell.2026.01.004.

MLA (9th ed.) Citation

JL, Gomez Marti, et al. "Enhancing Therapeutic Outcomes with Artificial Intelligence for HR-positive, HER2-negative Metastatic Breast Cancer." Cancer Cell, vol. 44, no. 2, 2026, p. 254, https://doi.org/10.1016/j.ccell.2026.01.004.